Shares of Abbott Laboratories dipped in premarket trading following reports of a new study showing that its approved COVID-19 testing kits have fallen short in accurately detecting the novel coronavirus.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,